TABLE 1.
Antimicrobial agent | % resistant isolates (no.) for: |
|||||
---|---|---|---|---|---|---|
EAEC |
ETEC |
|||||
Southeast Asia/India (n = 12) | Africa (n = 16) | Latin America (n = 11) | Southeast Asia/India (n = 14) | Africa (n = 18) | Latin America (n = 11) | |
Cefotaxime | 33.3 (4)a | 6.3 (1)a | 0 (0) | 42.9 (6)a | 0 (0) | 0 (0) |
Co-trimoxazole | 50(6) | 81.3 (13) | 36.4 (4) | 35.7 (5) | 61.1 (11) | 27.3 (3) |
Nalidixic acid | 66.7 (8) | 37.5 (6) | 27.3 (3) | 64.3 (9) | 38.9 (7) | 27.3 (3) |
Ciprofloxacin | 41.7 (5) | 18.8 (3) | 9.1 (1) | 42.9 (6) | 11.1 (2) | 9.1 (1) |
Azithromycin | 33.3 (4) | 25 (4) | 9.1 (1) | 28.6 (4) | 11.1 (2) | 0 (0) |
ESBL-producing strains.